|

Codrituzumab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1

Indications

  • Recurrent or Refractory Glypican 3 (GPC3)1
  • Primary Extra-cranial Solid Tumor1
  • Cancer1

Los Angeles, California1 trial

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Children's Hospital of Los Angeles (Data Collection Only)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.